๐Ÿš€ Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. ๐Ÿ”ฅ
Login

News on Medial

MOC Cancer Care raises $18 Mn led by Elevation Capital

EntrackrEntrackr ยท 4m ago
MOC Cancer Care raises $18 Mn led by Elevation Capital
Medial

MOC Cancer Care raises $18 Mn led by Elevation Capital MOC Cancer Care & Research Centre, a network of community cancer centres, has raised $18 million in funding led by Elevation Capital. Previously, MOC raised $10 million from Tata Capital Healthcare Fund in January 2023 to expand its operations and technological capabilities. The proceeds will be used to expand operations, open new centres, and diversify the range of services offered, said the Mumbai-based company. It operates in the daycare oncology space, focusing primarily on chemotherapy and the medical management of cancer. Founded in 2018 by oncologists Dr Ashish Joshi, Dr Kshitij Joshi, Dr Pritam Kalaskar and Dr Vashishth Maniar, MOC is a concept turned enterprise and a chain of community cancer centres that work to simplify the journey for cancer patients by building an ecosystem that embodies crucial aspects like proximity and affordability. Over the past seven years, MOC claims to have treated over 4.5 lakh cancer patients with a highly qualified team of 47 oncologists while scaling operations to 24 centres in Mumbai, Pune, Rest of Maharashtra, Ahmedabad, Indore, and Chhattisgarh. In May 2024, the company expanded its services by joining hands with Hemato Oncology Clinic (HOC), which was the second-largest independent chain of community cancer care centres in India. This merger has allowed the company to expand its operations in the state of Gujarat. MOC will soon expand its operations in Delhi NCR and other parts of India and develop a molecular oncology lab. Recently, Vivek Mathur, Partner and Chief Operating Officer (COO) at Elevation Capital, left the venture capital firm after 14 years to focus on advisory and mentorship.

5

Related News

Oncare bags $1 Mn in seed round led by Huddle Ventures

EntrackrEntrackr ยท 9m ago
Oncare bags $1 Mn in seed round led by Huddle Ventures
Medial

Oncare, a cancer care startup, has raised $1 million in its seed round led by Huddle Ventures. The round also saw participation from marquee institutional VCs such as TRTL Ventures, Cloud Capital, and DeVC. The proceeds will be used to expand its operations to 10 new centres across Delhi NCR, Bangalore, and Jaipur over the next two years. The funds will also be channelled towards team expansion and marketing efforts to raise awareness about the brandโ€™s affordable cancer care solutions. Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare is partnering with 50-100 bedded hospitals to create dedicated oncology wings. Through these partnerships, Oncare is reducing treatment costs by up to 40%. The brand claims to offer an affordable yet high-quality alternative to the expensive cancer treatmentโ€”often exceeding Rs 10 lakh in corporate hospitals. It also offers on-call nursing support to help patients manage side effects and anxiety associated with cancer therapies, without having to make unnecessary hospital visits. The startup is operational in South Delhi for the past 10 months and it has provided over 2,500 patients with guidance on treatment plans and claims to have completed over 500 treatment sessions. According to the annual Health of Nation report by Apollo Hospitals, the cancer burden in India is staggering, with yearly cases expected to rise from 1.39 million in 2020 to 1.57 million by 2025. However, high treatment costs, limited availability of oncology centres, and a shortage of specialised professionals are making cancer care inaccessible to millions.

Jobizo raises $1.4 Mn led by Alkemi Growth Capital

EntrackrEntrackr ยท 4m ago
Jobizo raises $1.4 Mn led by Alkemi Growth Capital
Medial

Jobizo raises $1.4 Mn led by Alkemi Growth Capital Healthcare HRtech firm Jobizo has raised $1.4 million in its pre-series funding round led by Alkemi Growth Capital. This investment follows the $500,000 seed funding round led by AROA Ventures in 2022. The proceeds will be used to create 100,000 healthcare jobs in India and 3,000 jobs abroad within the next 18 months and aims to complete 10 million job hours over time. Co-founded by Naveen Trehan and Avishek Agarwal, Jobizo is an AI-powered platform that connects employers with skilled professionals. The platform has contributed to over 10 million additional patient care hours in India. By using its expanding investor network and market expertise, Jobizo aims to create a welcoming environment for the workforce and tackle skill gap issues. Post seed round, Jobizo's growth claims to have grown over 500%, facilitated over 20,000 jobs in India and international countries, and helped fill over 10 million job hours.

Tvaster Genkalp raises $1.25 Mn in pre-Series A round

EntrackrEntrackr ยท 3m ago
Tvaster Genkalp raises $1.25 Mn in pre-Series A round
Medial

Title: Tvaster Genkalp raises $1.25 Mn in pre-Series A round Healthtech startup Tvaster Genkalp has raised $1.25 million in its pre-Series A round led by Ideaspring Capital. Existing backers such as Invigo Softwares and liver transplant expert Prof. Mohamed Rela also joined the round. The proceeds will be used to help expand and market Episcreenโ„ข Liver, a new blood test that can detect liver cancer early with 90% accuracy. This test offers a better option than the current standard, Alpha-Fetoprotein (AFP), which has only 50% sensitivity. Founded in 2021 by Dr. Srikar Raman and K. Sreedurgalakshmi, Tvaster is building high-accuracy, non-invasive tests for cancer. It aims to improve early detection and save lives, especially for liver cancer, which affects over 900,000 people globally every year. Tvaster has tested Episcreenโ„ข Liver on over 600 patients and plans to partner with top diagnostic labs for wider access. The firm is also working on tests for bile duct cancer and childhood liver cancer treatment resistance. It recently won the ILTS Young Researcher Award and received a BIRAC BIG Grant for its work in cancer diagnostics.

WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1

EntrackrEntrackr ยท 1m ago
WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1
Medial

WhiteHat Jr founder Karan Bajaj raises $16 Mn for new startup Complement1 WhiteHat Jr was acquired by Byjuโ€™s for $300 million three years ago. At the time, its CEO Karan Bajaj went on to lead Byjuโ€™s Future School before leaving the company in August 2021. Karan Bajaj, the co-founder of Byjuโ€™s-owned WhiteHat Jr, has raised $16 million in seed funding for his new startup Complement1. The round was led by Owl Ventures and Blume Ventures, with participation from other undisclosed investors. Complement1 is a cancer care startup focusing on personalized lifestyle coaching in the United States. According to the company, it is emerging from stealth to launch the first tech-enabled, clinically validated lifestyle modification platform for cancer patients and high-risk individualsโ€”delivering personalized, daily guidance and education through one-on-one dedicated CoActive Coaches. โ€œLifestyle change is one of the most powerful yet underused tools in cancer care,โ€ said Karan Bajaj, CEO and co-founder of Complement 1. โ€œEvery oncologist will tell you patients need more support incorporating clinically recommended physical activity, nutrition and mind-body practices. Weโ€™ve cracked the code on daily engagement with personalized, compassionate coachingโ€”helping patients make meaningful, lasting improvements during and beyond treatment.โ€ With this fundraise, Complement 1 plans to scale up its coaching infrastructure and operations across the United States, advance its AI-driven personalization engine, and partner with cancer centers, health plans, and employers to bring the program to their cancer patients, high-risk individuals, and survivors. A part of this funding company will also go towards product development to enhance the digital user experience for both patients and coaches.

Avammune Therapeutics raises $12 Mn in Series A round

EntrackrEntrackr ยท 1m ago
Avammune Therapeutics raises $12 Mn in Series A round
Medial

Avammune Therapeutics and its subsidiary, Avammune Lifesciences, have secured $12 million in a Series A financing round co-led by Capital 2B, Shastra VC, and Kotak Lifesciences Fund I. The proceeds will be utilized to accelerate its proprietary pipeline, which targets the innate immune system, to develop orally bioavailable small molecules and support the clinical development of lead candidate AVA-NP-695 (an ENPP1 inhibitor). Co-founded in 2020 by Arun B. Papaiah, Srinivasan Namala, and Aditya Kulkarni, Avammune Therapeutics is a biopharmaceutical company discovering small molecule medicines that target the innate immune system for the treatment of cancer and autoimmune disorders. Its pipeline targets Osteosarcoma, Ewingโ€™s Sarcoma, Triple-Negative Breast Cancer, GI cancers, and autoimmune disorders.

Comet raises $5 Mn in Series A round

EntrackrEntrackr ยท 1y ago
Comet raises $5 Mn in Series A round
Medial

D2C sneaker brand Comet has raised Rs 42.3 crore (approximately $5 million) in its Series A round led by Elevation Capital. This is the first round of investments for the Bengaluru-based company in 2024. The board at Comet has passed a special resolution to issue 10 equity and 50,076 Series A CCPS at an issue price of Rs 8,445 each to raise Rs 42.3 crore or $5 million, its regulatory filing accessed from the Registrar of Companies shows. Elevation Capital led the round with Rs 33.36 crore while existing investors Nexus Ventures and AngelList India participated with Rs 8.34 crore and Rs 60 lakhs respectively. The company will use these proceeds for capital expenditures, marketing, and general corporate purposes as per the business plan, the filing added. According to the startup data intelligence platform TheKredibe, Comet has been valued at around Rs 167 crore or $20 million post-allotment. The startup raised its seed capital in February last year. Following the fresh proceeds, Elevation Capital and Nexus Ventures will hold 20% each while AngelList India will command 2.22% of the capital in the company. Founded in July 2023, Comet is a homegrown, lifestyle sneaker brand for both men and women which sells its products through its website. Its current portfolio includes CometX, Aeon, and Slides. According to Comet, its TAM (total addressable market) is expected to be $22 billion while the companyโ€™s serviceable addressable market (SAM) is expected to be $1.5 billion by FY 2030. Comet competes with Wrong, HRX, Redtape, The Roadster, Campus, Sparx and other multinational footwear brands like Nike and Adidas.

Sugar.fit raises $5 Mn more in Series A led by B Capital

EntrackrEntrackr ยท 1y ago
Sugar.fit raises $5 Mn more in Series A led by B Capital
Medial

Sugar.fit, a healthtech focused on type 2 diabetes and prediabetes, has raised $5 million more in its Series A round led by B Capital with participation from MassMutual Ventures and existing investors including Tanglin Venture Partners, Endiya Partners, and Cure.fit (now Cult.fit). In October last year, the startup had raised $11 million in its Series A round led by MassMutual Ventures. The new capital will be used to expand Sugar.fitโ€™s technology stack and product range, increase brand presence, and speed up research and development in diabetes management, the company said in a press release. Founded by Madan Somasundaram, Sugar.fit offers a diabetes care program that combines innovative technology with personalized human interventions. Diabetes doctors and nutritionists use devices such as continuous glucose monitors, fitness trackers, and health diagnostics to monitor the real-time impact of usersโ€™ lifestyles on their glucose levels. In the last 18 months, the brand claims to have witnessed significant growth in paid subscribers, currently serving more than 30,000 users on its platform. The brand has also established an omnichannel presence, starting in Bengaluru, and now operates seven diabetes clinics with doctors in diabetes care across the city.

Download the medial app to read full posts, comements and news.